KPF
IRON icon

K2 Principal Fund’s Disc Medicine IRON Stock Holding History

K2 Principal Fund’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,437
Closed -$317K – 286
2022
Q3 		$317K Sell
6,437
-3,321
-34% -$157K 0.04% 164
2022
Q2 		$495K Buy
+9,758
New +$432K 0.05% 194

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

K2 Principal Fund's IRON Position: Q4 2022 in Review

K2 Principal Fund sold out of Disc Medicine (IRON) in Q4 2022, closing a stake of 6,437 shares — an estimated $317K sold.

K2 Principal Fund first reported a position in IRON in Q2 2022 and held it in 2 quarters. The position peaked at $495K in Q2 2022. 35 funds tracked by Wall St. Rank hold IRON as of Q4 2022.

  • K2 Principal Fund reported no remaining Disc Medicine position as of Q4 2022 after selling out during the quarter.
  • K2 Principal Fund sold 6,437 Disc Medicine shares in Q4 2022, an estimated $317K.
  • K2 Principal Fund first reported a position in Disc Medicine in Q2 2022 and held it in 2 quarters.
  • K2 Principal Fund's Disc Medicine position peaked at $495K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2022.

Based on K2 Principal Fund's 13F filing for Q4 2022, filed 10 Feb 2023.